Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
26/08/2026
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | 0.00% |
|
0.00% | -15.38% |
| Market Cap | 41.54M 29.92M 25.68M 24.1M 22.01M 2.85B 41.74M 285M 111M 1.44B 112M 110M 4.77B | P/E 2026 * |
-3.67x | P/E 2027 * | -2.75x |
|---|---|---|---|---|---|
| Enterprise Value | 41.54M 29.92M 25.68M 24.1M 22.01M 2.85B 41.74M 285M 111M 1.44B 112M 110M 4.77B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.31x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 3 months | -26.67% | ||
| 6 months | -21.43% | ||
| Current year | -15.38% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.12 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.2 |
| 3 years | 0.1 | | 0.91 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/26 | Sell | Company | -115,000 | 0.0305% | ||
| 22/5/26 | Option | Director | 173,418 | 0.0499% | ||
| 27/2/26 | Option | Director | 377,970 | 0.1123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -40.54% | -85.33% | 29.92M | |
| -0.28% | -3.03% | -16.40% | +18.54% | 126B | |
| +0.02% | -0.14% | -22.68% | -0.56% | 12.24B | |
| -0.45% | -4.74% | +92.53% | +144.41% | 10.65B | |
| +2.13% | -4.21% | -51.63% | -68.92% | 4.21B | |
| +0.57% | +4.02% | -22.01% | +58.76% | 2.77B | |
| +1.20% | +0.18% | -32.64% | -71.33% | 1.79B | |
| +1.12% | -0.84% | -23.32% | -12.99% | 1.66B | |
| +0.47% | -3.59% | -36.96% | -38.68% | 1.59B | |
| Average | +0.53% | -0.51% | -17.07% | -6.23% | 17.93B | |
| Weighted average by Cap. | -0.16% | -2.62% | -11.16% | +21.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.6M 3.09M 2.9M 2.65M 343M 5.02M 34.33M 13.3M 173M 13.52M 13.23M 574M |
| Net income | -12.83M -9.24M -7.93M -7.44M -6.8M -881M -12.89M -88.07M -34.13M -444M -34.68M -33.93M -1.47B | -19.77M -14.24M -12.22M -11.47M -10.48M -1.36B -19.87M -136M -52.61M -685M -53.46M -52.3M -2.27B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change |
|---|---|---|
| 26/08/26 | CA$0.1100 | 0.00% |
| 25/08/26 | CA$0.1100 | 0.00% |
| 24/08/26 | CA$0.1100 | 0.00% |
| 21/08/26 | CA$0.1100 | 0.00% |
| 20/08/26 | CA$0.1100 | 0.00% |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100CAD
Average target price
0.4500CAD
Spread / Average Target
+309.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
